Shakespeare T - Search Results

1

Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy.

Chua MS, Veness MJ, Morgan G, Shakespeare T, Hehir A, Gebski V, Cakir B, Tiver KW. Chua MS, et al. Among authors: shakespeare t. Australas Radiol. 2002 Jun;46(2):174-9. doi: 10.1046/j.1440-1673.2001.01030.x. Australas Radiol. 2002. PMID: 12060157

2

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours.

Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Shakespeare TP, et al. Lancet. 2001 Apr 28;357(9265):1349-53. doi: 10.1016/S0140-6736(00)04522-0. Lancet. 2001. PMID: 11343760 Review.

3

Estimating risks of radiotherapy complications as part of informed consent: the high degree of variability between radiation oncologists may be related to experience.

Shakespeare TP, Dwyer M, Mukherjee R, Yeghiaian-Alvandi R, Gebski V. Shakespeare TP, et al. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):647-53. doi: 10.1016/s0360-3016(02)02996-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377314

4

Evaluation of the quality of radiotherapy randomized trials for painful bone metastases.

Shakespeare TP, Thiagarajan A, Gebski V. Shakespeare TP, et al. Cancer. 2005 May 1;103(9):1976-81. doi: 10.1002/cncr.20993. Cancer. 2005. PMID: 15772960 Free article.

5

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.

Lu JJ, Shakespeare TP, Thiagarajan A, Zhang X, Liang L, Tan S. Lu JJ, et al. Laryngoscope. 2005 May;115(5):806-10. doi: 10.1097/01.MLG.0000157283.73284.A1. Laryngoscope. 2005. PMID: 15867644 Clinical Trial.

6

Interpreting the improved outcome of patients with central nervous system metastases managed in clinical trials compared with standard hospital practice.

Tang JI, Back M, Shakespeare T, Lu JJ, Mukherjee R, Wynne C, Liang S. Tang JI, et al. Among authors: shakespeare t. Australas Radiol. 2005 Oct;49(5):390-5. doi: 10.1111/j.1440-1673.2005.01500.x. Australas Radiol. 2005. PMID: 16174177

7

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.

Lu JJ, Kong L, Shakespeare TP, Loh KS, Zhang Q, Tan KS, Lee KM. Lu JJ, et al. Oral Oncol. 2008 Jul;44(7):703-9. doi: 10.1016/j.oraloncology.2007.09.005. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061528 Clinical Trial.

8

Influence of the way results are presented on research interpretation and medical decision making: the PRIMER collaboration randomized studies.

Shakespeare TP, Gebski V, Tang J, Lim K, Lu JJ, Zhang X, Jiang G. Shakespeare TP, et al. Med Decis Making. 2008 Jan-Feb;28(1):127-37. doi: 10.1177/0272989X07309640. Epub 2007 Dec 14. Med Decis Making. 2008. PMID: 18083993

9

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.

Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF. Leong CN, et al. Among authors: shakespeare tp. Cancer J. 2008 Jul-Aug;14(4):269-75. doi: 10.1097/PPO.0b013e318178d23a. Cancer J. 2008. PMID: 18677137

10

RANZCR 2006 peer review audit instrument.

Toohey J, Shakespeare TP, Morgan G. Toohey J, et al. Among authors: shakespeare tp. J Med Imaging Radiat Oncol. 2008 Aug;52(4):403-13. doi: 10.1111/j.1440-1673.2008.01939.x. J Med Imaging Radiat Oncol. 2008. PMID: 18811766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters